Mein Warenkorb

Claudin-6

Claudin-6 Molekülinformation

Englischer NameClaudin 6Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel13Target-AliasUNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameClaudin 6
Target-AliasUNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel13
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

Claudin-6 Produktliste

  • Attribut

    Protein (10)Cell (1)

  • Produktbibliothek

    Online (11)

  • Spezies

    Human (11)

  • Etikett

    His Tag & Strep Tag (2)His Tag & Flag Tag & GFP Tag (2)GFP Tag (1)- (5)Flag Tag & His Tag & Strep Tag (1)

  • Marker

    Unconjugated (5)GFP Fusion (2)- (1)Biotin-labeled (3)

Claudin-6 Molekülhintergrund

Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. Claudin-6, also knows as CLDN6, is a multipass transmembrane protein in the Claudin family. Claudin-6 is expressed by epithelial cells where it participates in tissue development and the maintenance of tight junction integrity. And it is one of the entry cofactors for hepatitis C virus. The methylation of CLDN6 may be involved in esophageal tumorigenesis. The gene of CLDN6 is adjacent to another family member CLDN9 on chromosome 16.

Claudin-6 Molekülalias

Claudin-6,CLDN6

Antikörperprojekt-Handelsplattform

ProjektnameProjektphaseMolekültypMolekülquelleKrankheitsgebietIndikationen
CLDN6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Lung adenocarcinoma

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
QLS-5132QLS5132; QLS-5132Phase 2 ClinicalQilu Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms
Details
TORL-1-23TORL-1-23Phase 2 ClinicalTorl Biotherapeutics LLCCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours
Details
PLB-002PLB-002; PLB002Phase 1 ClinicalPrimeLink BioTherapeuticsEndometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
Details
BGB-B455BGB-B455Phase 1 ClinicalBeOne Medicines LtdSolid tumours
Details
AT03-65AT-03-65; AT03-65Phase 1 ClinicalAxcynsis Therapeutics Pte LtdSolid tumours
Details
ARC-101ARC101; ARC-101Phase 1 ClinicalThird Arc Bio IncEndometrial Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Solid tumours
Details
CTIM-76CTIM-76Phase 1 ClinicalIntegral Molecular IncEndometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
Details
NBL-028NBL028; NBL-028Phase 1 ClinicalNovarock Biotherapeutics Ltd, Shanghai Xinshi Biological Medicine Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Testicular Neoplasms
Details
XmAb-541XmAb541; XmAb-541Phase 1 ClinicalXencor IncEndometrial Neoplasms; Germinoma; Neoplasms, Germ Cell and Embryonal; Ovarian germ cell tumor; Ovarian Neoplasms
Details
SAIL-66SAIL66; SAIL-66Phase 1 ClinicalChugai Pharmaceutical Co LtdSolid tumours
Details
CLDN6-CAR-NK Cell TherapyPhase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical UniversityEndometrial Neoplasms; Ovarian Neoplasms
Details
TJ-C64BTJ-C64BPhase 1 ClinicalI-Mab Biopharma Co LtdOvarian Neoplasms; Stomach Neoplasms
Details
CLDN6 CAR-T cell therapy (BioNTech)BNT-211Phase 1 ClinicalBiontech SeGerminoma; Neoplasms, Gonadal Tissue; Solid tumours; Testicular Neoplasms
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns